March 15, 2021
Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update
– Firdapse® Q4-20 Net Revenues of $31.0 Million, FY-20 Net Revenues of $119.1 Million – GAAP Net Income of $75.0 Million for Fiscal Year 2020 – $140.3 Million in Cash and Investments and No Funded Debt – Company to Host Quarterly Conference Call at …